Toshiaki Homma
About
In The Last Decade
Toshiaki Homma
28 papers receiving 541 citations
Peers
Comparison fields: 5 of 96
- Pulmonary and Respiratory Medicine 194
- Environmental Engineering 113
- Pollution 109
- Health, Toxicology and Mutagenesis 84
- Physiology 73
Countries citing papers authored by Toshiaki Homma
This map shows the geographic impact of Toshiaki Homma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiaki Homma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiaki Homma more than expected).
Fields of papers citing papers by Toshiaki Homma
This network shows the impact of papers produced by Toshiaki Homma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiaki Homma. The network helps show where Toshiaki Homma may publish in the future.
Co-authorship network of co-authors of Toshiaki Homma
This figure shows the co-authorship network connecting the top 25 collaborators of Toshiaki Homma. A scholar is included among the top collaborators of Toshiaki Homma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshiaki Homma. Toshiaki Homma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | [Reduced ADL, QOL and musculoskeletal dysfunction associated with respiratory disease.] | 1 |
| 2 | 73 | |
| 3 | 51 | |
| 4 | 28 | |
| 5 | 16 | |
| 6 | 1 | |
| 7 | 11 | |
| 8 | 32 | |
| 9 | 11 | |
| 10 | 6 | |
| 11 | 135 | |
| 12 | 36 | |
| 13 | 22 | |
| 14 | Depression in COPD Patients | 1 |
| 15 | 12 | |
| 16 | [Alpha 1-antitrypsin deficiency (Siiyama) with pulmonary emphysema]. | 2 |
| 17 | 4 | |
| 18 | [Effects of pulmonary rehabilitation on vital capacity in patients with chronic pulmonary emphysema]. | 1 |
| 19 | [Clinical use of the measurement of functional residual capacity during non-panting breathing--study on healthy subjects and respiratory patients]. | 1 |
| 20 | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.